Last edition
News about Market
U.S. Food and Drug Administration grants Priority Review and Breakthrough Therapy status to combination therapy showing significant survival benefits in advanced HER2-positive gastric and esophageal cancers.
Market | 01/05/2026 | By News Bureau
Parexel Acquires Vitrana to Boost Patient Safety Solutions
Parexel acquires Vitrana to enhance patient safety solutions with an Artificial Intelligence (AI)-enabled platform offering integrated pharmacovigilance, improved efficiency, and stronger regulatory compliance.
Market | 01/05/2026 | By News Bureau
Chiesi Group to Acquire KalVista Pharmaceuticals to Expand Rare Disease Portfolio
Chiesi Group to acquire KalVista Pharmaceuticals for USD 1.9 billion, adding an oral on-demand therapy for hereditary angioedema and strengthening its global rare disease portfolio, with closing expected in Q3 2026.
Market | 30/04/2026 | By News Bureau
Gilead Sciences Completes Arcellx Inc. Acquisition Ahead of Anito-cel Launch
Under the terms of the transaction, Gilead acquired Arcellx for USD 115 per share in cash, plus one non?transferable Contingent Value Right (CVR) of USD 5 per share, representing a total implied equity value of approximately USD 7.8 billion at the time of closing.
Market | 29/04/2026 | By News Bureau
Thermo Fisher to Sell Microbiology Business to Astorg in USD 1.07 Billion Deal
Thermo Fisher’s microbiology business, which generated USD 645 million in 2025 revenue, will transition to Astorg as part of a strategic portfolio realignment.
Market | 29/04/2026 | By News Bureau | 119
Akums Launches Aztreonam-Avibactam to Combat Drug-Resistant Infections
Akums launches Aztreonam-Avibactam, an advanced antibiotic for severe drug-resistant infections, offering a new treatment option for life-threatening infections in intensive care settings.
Market | 29/04/2026 | By News Bureau | 129
IMG Pharma to Acquire Matsumoto Pharmaceutical
IMG Pharma signs a definitive agreement to acquire Matsumoto Pharmaceutical, combining biopharmaceutical innovation with manufacturing and OTC capabilities, forming a multi-layered product capability structure.
Market | 28/04/2026 | By News Bureau
Xcovery Partners with EVERSANA to Launch Ensacove in US
Xcovery Holdings Inc. partners with EVERSANA to commercialize Ensacove in the U.S., leveraging end-to-end services including market access, medical and commercial support to expand lung cancer treatment availability.
Market | 28/04/2026 | By News Bureau
Eli Lilly and Company to Acquire Ajax Therapeutics to Expand Blood Cancer Pipeline
Eli Lilly and Company to acquire Ajax Therapeutics, advancing its blood cancer pipeline with AJ1-11095, a Phase 1 JAK2 inhibitor targeting myelofibrosis and polycythemia vera, with potential for improved disease control.
Market | 28/04/2026 | By News Bureau
Sun Pharmaceutical Industries Signs Definitive Agreement to Acquire Organon
Sun Pharmaceutical Industries signs a definitive agreement to acquire Organon for USD 14 per share, valuing the deal at USD 11.75B EV. The merger aims to leverage complementary portfolios and global scale for long-term growth.
Market | 27/04/2026 | By News Bureau | 157
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy